Invesaro

Stocks AYTU Earnings

Earnings

Aytu Biopharma, Inc (AYTU) earnings

Quarterly results of Aytu Biopharma, Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when AYTU files with the SEC.

Next earnings date

Aytu Biopharma, Inc is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q4 FY2026

In Q4 FY2026 (ended June 30, 2026) Aytu Biopharma, Inc reported revenue of $16.1M (+6.4% on the same quarter a year earlier) and a net loss of $15K.

Filed with the SEC on September 22, 2026.

The latest results release

Aytu BioPharma reported fourth quarter net revenue of $16.1 million and full year fiscal 2026 net revenue of $57.6 million.

Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarter.

September 22, 2026 · Read the release explained

Revenue by quarter
Q1 25: $16.6M $16.6M Q1 25Q2 25: $16.2M $16.2M Q2 25Q3 25: $18.5M $18.5M Q3 25Q4 25: $15.1M $15.1M Q4 25Q1 26: $13.9M $13.9M Q1 26Q2 26: $15.2M $15.2M Q2 26Q3 26: $12.4M $12.4M Q3 26Q4 26: $16.1M $16.1M Q4 26
Net income by quarter
Q1 25: $1.5M $1.5M Q1 25Q2 25: $788K $788K Q2 25Q3 25: $4M $4M Q3 25Q4 25: -$19.8M -$19.8M Q4 25Q1 26: $2M $2M Q1 26Q2 26: -$10.6M -$10.6M Q2 26Q3 26: -$5.6M -$5.6M Q3 26Q4 26: -$15K -$15K Q4 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q4 FY2026June 30, 2026$16.1M+6.4%-$15K-
Q3 FY2026March 31, 2026$12.4M-32.7%-$5.6M-$0.53
Q2 FY2026December 31, 2025$15.2M-6.5%-$10.6M-$1.05
Q1 FY2026September 30, 2025$13.9M-16.2%$2M-$0.08
Q4 FY2025June 30, 2025$15.1M--$19.8M-
Q3 FY2025March 31, 2025$18.5M-$4M$0.21
Q2 FY2025December 31, 2024$16.2M-$788K-$0.26
Q1 FY2025September 30, 2024$16.6M-$1.5M-$0.15

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Aytu Biopharma, Inc's next earnings date?

Aytu Biopharma, Inc is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Aytu Biopharma, Inc's latest quarterly results?

For Q4 FY2026, which ended June 30, 2026, Aytu Biopharma, Inc reported revenue of $16.1M and a net loss of $15K. The figures come from its filing with the SEC.

Is Aytu Biopharma, Inc's revenue growing?

Revenue in Q4 FY2026 was $16.1M, up 6.4% from $15.1M in the same quarter a year earlier.

Get an email when AYTU reports

Follow AYTU and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when AYTU files with the SEC.

Source: quarterly figures Aytu Biopharma, Inc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Aytu Biopharma, Inc